Managing endothelial dysfunction in COVID‐19 with statins, beta blockers, nicorandil, and oral supplements: A pilot, double‐blind, placebo‐controlled, randomized clinical trial

• Main Authors: Kamal Matli (Author), Abdulrahman Al Kotob (Author), Wassim Jamaleddine (Author), Soad Al Osta (Author), Pascale Salameh (Author), Rami Tabbikha (Author), Nibal Chamoun (Author), Ahmad Moussawi (Author), Jean‐Michel Saad (Author), Gibran Atwi (Author), Tarik Abu Saad (Author), Omar Jamal (Author), Jacques Mokhbat (Author), Georges Ghanem (Author)
• Format: Book
• Published: Wiley, 2022-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Coronavirus disease 2019 (COVID‐19) is associated with endothelial dysfunction. Pharmacologically targeting the different mechanisms of endothelial dysfunction may improve clinical outcomes and lead to reduced morbidity and mortality. In this pilot, double‐blind, placebo‐controlled, randomi...